CSPC Pharmaceutical Grants 46.5 Million Restricted Shares to 727 Employees
I'm PortAI, I can summarize articles.
CSPC Pharmaceutical Group has granted 46.5 million restricted shares to 727 employees as part of its equity incentive scheme. This represents about 0.4% of its issued share capital, with shares vesting in three tranches from January 2027 to January 2029, contingent on performance targets. The company retains 61.6 million shares for future grants. The latest analyst rating for CSPC stock (HK:1093) is a Hold with a price target of HK$10.50. CSPC focuses on the research, development, and sale of pharmaceuticals in both domestic and international markets.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments